Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sequential delivery of PD-1/PD-L1 blockade peptide and IDO inhibitor for immunosuppressive microenvironment remodeling via an MMP-2 responsive dual-targeting liposome
Chuan Hu, Yujun Song, Yiwei Zhang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 5, pp. 2176-2187
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
Yuzhi Jin, Yangyue Huang, Hui Ren, et al.
Biomaterials (2024) Vol. 305, pp. 122463-122463
Closed Access | Times Cited: 42
Stimulus Responsive Nanocarrier for Enhanced Antitumor Responses Against Hepatocellular Carcinoma
Deteng Zhang, Jinxiao Song, Zhenghui Jing, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 13339-13355
Open Access | Times Cited: 25
Breaking Physical Barrier of Fibrotic Breast Cancer for Photodynamic Immunotherapy by Remodeling Tumor Extracellular Matrix and Reprogramming Cancer-Associated Fibroblasts
Ziwen Qiu, Yingtao Zhong, Zhen‐Ming Lu, et al.
ACS Nano (2024) Vol. 18, Iss. 13, pp. 9713-9735
Closed Access | Times Cited: 21
Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy
Xueqiang Peng, Jianjun Fang, Chuyuan Lou, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3432-3456
Open Access | Times Cited: 20
Cutting-edge approaches for targeted drug delivery in breast cancer: beyond conventional therapies
Ramesh Chaudhari, Vishva Patel, Ashutosh Kumar
Nanoscale Advances (2024) Vol. 6, Iss. 9, pp. 2270-2286
Open Access | Times Cited: 16
For and against tumor microenvironment: Nanoparticle-based strategies for active cancer therapy
Soroush Karimi, Roksana Bakhshali, Soheil Bolandi, et al.
Materials Today Bio (2025) Vol. 31, pp. 101626-101626
Open Access | Times Cited: 2
Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 12
Metformin‐Mediated Immunosuppressive Microenvironment Remodeling in Combination with Chemotherapy via a Spatial‐Specific Multi‐Responsive Carrier‐Free Self‐Assembled Nanoparticle
Yujun Song, Yufan Du, Chuan Hu, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 25
Closed Access | Times Cited: 10
Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope
Xiaojie Zhang, Bufu Tang, Jinhua Luo, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Mitochondrial metabolism blockade nanoadjuvant reversed immune-resistance microenvironment to sensitize albumin-bound paclitaxel-based chemo-immunotherapy
Zaigang Zhou, Wenjuan Luo, Chunjuan Zheng, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 4087-4101
Open Access | Times Cited: 8
Anti-tumor immune potentiation targets-engineered nanobiotechnologies: Design principles and applications
Rong Jiao, Xia Lin, Qian Zhang, et al.
Progress in Materials Science (2023) Vol. 142, pp. 101230-101230
Closed Access | Times Cited: 20
Matrix Metalloproteinase-Responsive Drug Delivery Systems
Chenyun Zhang, Gan Jiang, Xiaoling Gao
Bioconjugate Chemistry (2023) Vol. 34, Iss. 8, pp. 1349-1365
Closed Access | Times Cited: 16
Charting new frontiers: Co-inhibitory immune checkpoint proteins in therapeutics, biomarkers, and drug delivery systems in cancer care
Yao Xiao, Zi‐Zhan Li, Nian‐Nian Zhong, et al.
Translational Oncology (2023) Vol. 38, pp. 101794-101794
Open Access | Times Cited: 16
Enzyme/pH Dual-Responsive Engineered Nanoparticles for Improved Tumor Immuno-Chemotherapy
Zefeng Liu, Xiaohan Hao, Jieying Qian, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 10, pp. 12951-12964
Closed Access | Times Cited: 7
Nanotechnology-based in situ cancer vaccines: Mechanisms, design, and recent advances
Gaoli Niu, Hong Wang, Yanhong Zhai, et al.
Nano Today (2024) Vol. 56, pp. 102286-102286
Closed Access | Times Cited: 7
A POSS-Based Metal-Phenolic Network with Coupled Hardness and Softness for Photodynamic-Immunotherapy of Triple-Negative Breast Cancer
Wei Wang, Luanfeng Liao, Yun Huang, et al.
ACS Materials Letters (2024) Vol. 6, Iss. 6, pp. 2369-2380
Closed Access | Times Cited: 7
Revolutionizing cancer treatment: The power of cell-based drug delivery systems
Lu Qi, Tian Liu, Zeyu Han, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 604-620
Open Access | Times Cited: 14
Nanoparticle drug delivery systems responsive to tumor microenvironment: Promising alternatives in the treatment of triple‐negative breast cancer
Ye Cao, Fansu Meng, Tiange Cai, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 2
Closed Access | Times Cited: 5
Bio-orthogonal click chemistry strategy for PD-L1-targeted imaging and pyroptosis-mediated chemo-immunotherapy of triple-negative breast cancer
Yan Wang, Yanhong Chen, Ding‐Kun Ji, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Coacervation‐Driven Semipermeable Nanoreactors for Enzymatic Cascade‐Mediated Cancer Combination Therapy with Enhanced Efficacy
Min Lin, Xueli Lv, Hepeng Wang, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 5
Targeted Nanoprobes Enabled Precision Theranostics in Triple‐Negative Breast Cancer
Ke Ma, Meng Yin, Kezheng Chen, et al.
The Chemical Record (2025)
Closed Access
Polysaccharide nanoparticles as potential immune adjuvants: Mechanism and function
Yuhong Jiang, Shanshan Qi, Canquan Mao
Acta Pharmaceutica Sinica B (2025)
Open Access
Sulfafurazole dimers potentiate chemo-immunotherapy of low immunogenic breast cancer by preventing the PD-L1 exosomes secretion
Zheng Wang, Ronghui Yin, Long Zhang, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
NQO1-activated multifunctional theranostic probe for imaging-guided mitochondria-targeted photodynamic therapy and boosting immunogenic cell death
Chen Cao, Jiansen Li, Xinlu Zhang, et al.
Talanta (2024) Vol. 272, pp. 125786-125786
Closed Access | Times Cited: 3
Supramolecular artificial Nano-AUTACs enable tumor-specific metabolism protein degradation for synergistic immunotherapy
Yazhen Wang, Lianyi Yang, C. Yan, et al.
Science Advances (2024) Vol. 10, Iss. 25
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top